342
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Cyproterone acetate-loaded nanostructured lipid carriers: effect of particle size on skin penetration and follicular targeting

ORCID Icon, , , ORCID Icon, & ORCID Icon
Pages 812-823 | Received 01 Jul 2018, Accepted 06 Mar 2019, Published online: 26 Apr 2019

References

  • Adib ZM, Ghanbarzadeh S, Kouhsoltani M, Khosroshahi AY, Hamishehkar H. 2016. The effect of particle size on the deposition of solid lipid nanoparticles in different skin layers: a histological study. Adv Pharm Bull. 6:31.
  • Agrawal U, Gupta M, Vyas S. 2015. Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis. Artif Cells Nanomed Biotechnol. 43:33–39.
  • Arıca Yegin B, Benoît J-P, Lamprecht A. 2006. Paclitaxel-loaded lipid nanoparticles prepared by solvent injection or ultrasound emulsification. Drug Dev Ind Pharm. 32:1089–1094.
  • Azadi A, Hamidi M, Rouini M-R. 2013. Methotrexate-loaded chitosan nanogels as 'Trojan Horses' for drug delivery to brain: preparation and in vitro/in vivo characterization. Int J Biol Macromol. 62:523–530.
  • Beloqui A, Solinis MA, Rodriguez-Gascon A, Almeida AJ, Preat V. 2016. Nanostructured lipid carriers: promising drug delivery systems for future clinics. Nanomedicine. 12:143–161.
  • Chandross R, Bordner J. 1974. The crystal structure of a potent anti-androgen: cyproterone acetate (6-chloro-17-hydroxy-1α, 2α-methylenepregna-4, 6-diene-3, 20-dione acetate). Acta Crystallogr B Struct Crystallogr Cryst Chem. 30:1581–1585.
  • Chauhan H, Mohapatra S, Munt DJ, Chandratre S, Dash A. 2016. Physical-chemical characterization and formulation considerations for solid lipid nanoparticles. AAPS PharmSciTech. 17:640–651.
  • Chen D-B, Yang T-z, Lu W-L, Zhang Q. 2001. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel. Chem Pharm Bull. 49:1444–1447.
  • Chen J, Wei N, Lopez-Garcia M, Ambrose D, Lee J, Annelin C, Peterson T. 2017. Development and evaluation of resveratrol, Vitamin E, and epigallocatechin gallate loaded lipid nanoparticles for skin care applications. Eur J Pharm Biopharm. 117:286–291.
  • Chen W, Palazzo A, Hennink WE, Kok RJ. 2017. Effect of particle size on drug loading and release kinetics of gefitinib-loaded PLGA microspheres. Mol Pharm. 14:459–467.
  • Chetoni P, Burgalassi S, Monti D, Tampucci S, Tullio V, Cuffini AM, Muntoni E, Spagnolo R, Zara GP, Cavalli R. 2016. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: pharmacokinetic studies on rabbits. Eur J Pharm Biopharm. 109:214–223.
  • Cipolla D, Shekunov B, Blanchard J, Hickey A. 2014. Lipid-based carriers for pulmonary products: preclinical development and case studies in humans. Adv Drug Deliv Rev. 75:53–80.
  • Dal Magro R, Ornaghi F, Cambianica I, Beretta S, Re F, Musicanti C, Rigolio R, Donzelli E, Canta A, Ballarini E. 2017. ApoE-modified solid lipid nanoparticles: a feasible strategy to cross the blood-brain barrier. J Control Release. 249:103–110.
  • Das S, Ng WK, Tan RB. 2012. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci. 47:139–151.
  • Doktorovova S, Kovacevic AB, Garcia ML, Souto EB. 2016. Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: current evidence from in vitro and in vivo evaluation. Eur J Pharm Biopharm. 108:235–252.
  • Fang C-L, A Al-Suwayeh S, Fang J-Y. 2013. Nanostructured lipid carriers (NLCs) for drug delivery and targeting. Recent Pat Nanotechnol. 7:41–55.
  • Fernandes B, Silva R, Ribeiro A, Matamá T, Gomes A, Cavaco ‐, Paulo A. 2015. Improved poly (D,L-lactide) nanoparticles-based formulation for hair follicle targeting. Int J Cosmet Sci. 37:282–290.
  • Fontana G, Maniscalco L, Schillaci D, Cavallaro G, Giammona G. 2005. Solid lipid nanoparticles containing tamoxifen characterization and in vitro antitumoral activity. Drug Deliv. 12:385–392.
  • Garud A, Singh D, Garud N. 2012. Solid lipid nanoparticles (SLN): Method, characterization and applications. International Current Pharmaceutical Journal. 1(11):384–393.
  • Ghasemiyeh P, Azadi A, Daneshamouz S, Samani SM. 2017. Cyproterone acetate-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): preparation and optimization. Trends Pharm Sci. 3:275–286.
  • Ghasemiyeh P, Mohammadi-Samani S. 2018. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Res Pharm Sci. 13:288.
  • Hou D, Xie C, Huang K, Zhu C. 2003. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials. 24:1781–1785.
  • Hu C, Qian A, Wang Q, Xu F, He Y, Xu J, Xia Y, Xia Q. 2016. Industrialization of lipid nanoparticles: from laboratory-scale to large-scale production line. Eur J Pharm Biopharm. 109:206–213.
  • Jaiswal P, Gidwani B, Vyas A. 2016. Nanostructured lipid carriers and their current application in targeted drug delivery. Artif Cells Nanomed Biotechnol. 44:27–40.
  • Kelidari H, Saeedi M, Akbari J, Morteza-Semnani K, Gill P, Valizadeh H, Nokhodchi A. 2015. Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles. Colloids Surf B Biointerfaces. 128:473–479.
  • Kelidari H, Saeedi M, Akbari J, Morteza-Semnani K, Valizadeh H, Maniruzzaman M, Farmoudeh A, Nokhodchi A. 2017. Development and optimisation of spironolactone nanoparticles for enhanced dissolution rates and stability. AAPS PharmSciTech. 18:1469–1474.
  • Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. 1983. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 15:25–35.
  • Korsmeyer RW, Peppas NA. 1981. Effect of the morphology of hydrophilic polymeric matrices on the diffusion and release of water soluble drugs. J Memb Sci. 9:211–227.
  • Lademann J, Patzelt A, Richter H, Antoniou C, Sterry W, Knorr F. 2009. Determination of the cuticula thickness of human and porcine hairs and their potential influence on the penetration of nanoparticles into the hair follicles. J Biomed Opt. 14:021014.
  • Lauterbach A, Müller-Goymann CC. 2014. Comparison of rheological properties, follicular penetration, drug release, and permeation behavior of a novel topical drug delivery system and a conventional cream. Eur J Pharm Biopharm. 88:614–624.
  • Lauterbach A, Muller-Goymann CC. 2015. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route. Eur J Pharm Biopharm. 97:152–163.
  • Liu D, Liu Z, Wang L, Zhang C, Zhang N. 2011. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf B Biointerfaces. 85:262–269.
  • Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X. 2007. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 328:191–195.
  • Luo Y, Chen D, Ren L, Zhao X, Qin J. 2006. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Release. 114:53–59.
  • Mohammadi-Samani S, Jalali F, Tavakoli S, Ahmadi F. 2014. Solid lipid microparticles of lamotrigine: an injectable controlled release system for local delivery in nerve injuries. J Drug Deliv Sci Technol. 24:367–372.
  • Mohammadi-Samani S, Montaseri H, Jamshidnejad M. 2009. Preparation and evaluation of cyproterone acetate liposome for topical drug delivery. Iran J Pharm Sci. 5:199–204.
  • Mojahedian MM, Daneshamouz S, Samani SM, Zargaran A. 2013. A novel method to produce solid lipid nanoparticles using n-butanol as an additional co-surfactant according to the o/w microemulsion quenching technique. Chem Phys Lipids. 174:32–38.
  • Monti D, Tampucci S, Burgalassi S, Chetoni P, Lenzi C, Pirone A, Mailland F. 2014. Topical formulations containing finasteride. Part I: in vitro permeation/penetration study and in vivo pharmacokinetics in hairless rat. J Pharm Sci. 103:2307–2314.
  • Müller RH, Mäder K, Gohla S. 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm. 50:161–177.
  • Müller R, Schwarz C, Zur Mühlen A, Mehnert W. 1994. Incorporation of lipophilic drugs and drug release profiles of solid lipid nanoparticles (SLN). Int Symp Control Release Bioact Mater. 21:146–147.
  • Nnamani PO, Hansen S, Windbergs M, Lehr C-M. 2014. Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application. Int J Pharm. 477:208–217.
  • Park JH, Ban SJ, Ahmed T, Choi HS, Yoon HE, Yoon JH, Choi HK. 2015. Development of DH-I-180-3 loaded lipid nanoparticle for photodynamic therapy. Int J Pharm. 491:393–401.
  • Patzelt A, Richter H, Knorr F, Schäfer U, Lehr C-M, Dähne L, Sterry W, Lademann J. 2011. Selective follicular targeting by modification of the particle sizes. J Control Release. 150:45–48.
  • Pradhan M, Singh D, Singh MR. 2017. Fabrication, optimization and characterization of triamcinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis: application of Box Behnken design, in vitro and ex vivo studies. J Drug Deliv Sci Technol. 41:325–333.
  • Puglia C, Lauro MR, Offerta A, Crascì L, Micicchè L, Panico AM, Bonina F, Puglisi G. 2017. Nanostructured lipid carriers (NLC) as vehicles for topical administration of sesamol: in vitro percutaneous absorption study and evaluation of antioxidant activity. Planta Med. 83:398–404.
  • Rancan F, Afraz Z, Combadiere B, Blume-Peytavi U, Vogt A. 2013. Hair follicle targeting with nanoparticles. Nanotechnology in dermatology. Amazon:Springer; p. 95–107.
  • Sánchez-López E, Espina M, Doktorovova S, Souto EB, García ML. 2017. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles. Eur J Pharm Biopharm. 110:58–69.
  • Severino P, Andreani T, Macedo AS, Fangueiro JF, Santana MHA, Silva AM, Souto EB. 2012. Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. J Drug Deliv. 2012:1–10.
  • Shah M. 2017. Solid lipid nanoparticles (SLN) for oral drug delivery: an overview. J Nanomed Nanosci. 2017(2):1–2. DOI: 10.29011/JNAN109-100009.
  • Shah RM, Malherbe F, Eldridge D, Palombo EA, Harding IH. 2014. Physicochemical characterization of solid lipid nanoparticles (SLNs) prepared by a novel microemulsion technique. J Colloid Interface Sci. 428:286–294.
  • Shidhaye S, Vaidya R, Sutar S, Patwardhan A, Kadam V. 2008. Solid lipid nanoparticles and nanostructured lipid carriers-innovative generations of solid lipid carriers. Curr Drug Deliv. 5:324–331.
  • Tampucci S, Burgalassi S, Chetoni P, Lenzi C, Pirone A, Mailland F, Caserini M, Monti D. 2014. Topical formulations containing finasteride. Part II: determination of finasteride penetration into hair follicles using the differential stripping technique. J Pharm Sci. 103:2323–2329.
  • Tokton N, Ounaroon A, Panichayupakaranant P, Tiyaboonchai W. 2014. Development of ellagic acid rich pomegranate peel extract loaded nanostructured lipid carriers (NLCS). Int J Pharm Pharm Sci. 6:259–265.
  • Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi U. 2004. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol. 123:168–176.
  • Trotta M, Debernardi F, Caputo O. 2003. Preparation of solid lipid nanoparticles by a solvent emulsification–diffusion technique. Int J Pharm. 257:153–160.
  • Tursilli R, Piel G, Delattre L, Scalia S. 2007. Solid lipid microparticles containing the sunscreen agent, octyl-dimethylaminobenzoate: effect of the vehicle. Eur J Pharm Biopharm. 66:483–487.
  • Wosicka-Frąckowiak H, Cal K, Stefanowska J, Główka E, Nowacka M, Struck-Lewicka W, Govedarica B, Pasikowska M, Dębowska R, Jesionowski T, et al. 2015. Roxithromycin-loaded lipid nanoparticles for follicular targeting. Int J Pharm. 495:807–815.
  • Zhang C, Peng F, Liu W, Wan J, Wan C, Xu H, Lam CW, Yang X. 2014. Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats. Int J Nanomedicine. 9:1049.
  • zur Mühlen A, Schwarz C, Mehnert W. 1998. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur J Pharm Biopharm. 45:149–155.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.